Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Dronabinol

Next Previous
X
Search
Drug Profile

Dronabinol

Alternative Names: 9-THC; Delta9-Tetrahydrocannabinol; Deltanyne; Dronabinol inhaled; Elevat; Marinol; NSC-134454; Pulmonary dronabinol - Solvay/Nektar Therapeutics; δ9-tetrahydrobannabinol

Latest Information Update: 05 Nov 2023

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Unimed Pharmaceuticals
  • Developer Nektar Therapeutics; Unimed Pharmaceuticals
  • Class Antidementias; Antiemetics; Antineoplastics; Appetite stimulants; Cannabinoids; Chromans; Muscle relaxants; Non-opioid analgesics; Small molecules
  • Mechanism of Action Cannabinoid receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Anorexia nervosa
  • New Molecular Entity No

Highest Development Phases

  • Marketed Anorexia nervosa; Nausea and vomiting
  • Discontinued Migraine

Most Recent Events

  • 31 Oct 2005 Phase-II clinical trials in Migraine (Inhalation)
  • 20 May 2005 Data from a media release have been added to the Advances in the Treatment of Nausea and Migraine therapeutic trials section
  • 29 Apr 2005 Data presented at the 57th Annual Meeting of the American Academy of Neurology (AAN-2005) have been added to the adverse events and pharmacokinetics sections

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top